↓ Skip to main content

Statistical analysis plan for the Balanced Solution versus Saline in Intensive Care Study (BaSICS)

Overview of attention for article published in Revista Brasileira de Terapia Intensiva, January 2020
Altmetric Badge


3 Dimensions

Readers on

17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Statistical analysis plan for the Balanced Solution versus Saline in Intensive Care Study (BaSICS)
Published in
Revista Brasileira de Terapia Intensiva, January 2020
DOI 10.5935/0103-507x.20200081
Pubmed ID

Lucas Petri Damiani, Alexandre Biasi Cavalcanti, Rodrigo Santos Biondi, Flávio Geraldo Rezende de Freitas, Rodrigo Cruvinel Figueiredo, Wilson José Lovato, Cristina Prata Amêndola, Ary Serpa, Jorge Luiz da Rocha Paranhos, Viviane Cordeiro Veiga, Marco Antonio Vieira Guedes, Eraldo de Azevedo Lúcio, Lúcio Couto Oliveira, Thiago Costa Lisboa, Fabio Holanda Lacerda, Tamiris Abait Miranda, Israel Silva Maia, Cintia Magalhães Carvalho Grion, Flavia Ribeiro Machado, Fernando Godinho Zampieri


To report the statistical analysis plan (first version) for the Balanced Solutions versus Saline in Intensive Care Study (BaSICS). BaSICS is a multicenter factorial randomized controlled trial that will assess the effects of Plasma-Lyte 148 versus 0.9% saline as the fluid of choice in critically ill patients, as well as the effects of a slow (333mL/h) versus rapid (999mL/h) infusion speed during fluid challenges, on important patient outcomes. The fluid type will be blinded for investigators, patients and the analyses. No blinding will be possible for the infusion speed for the investigators, but all analyses will be kept blinded during the analysis procedure. BaSICS will have 90-day mortality as its primary endpoint, which will be tested using mixed-effects Cox proportional hazard models, considering sites as a random variable (frailty models) adjusted for age, organ dysfunction and admission type. Important secondary endpoints include renal replacement therapy up to 90 days, acute renal failure, organ dysfunction at days 3 and 7, and mechanical ventilation-free days within 28 days. This manuscript provides details on the first version of the statistical analysis plan for the BaSICS trial and will guide the study's analysis when follow-up is finished.

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 18%
Student > Doctoral Student 2 12%
Other 2 12%
Student > Postgraduate 2 12%
Student > Ph. D. Student 1 6%
Other 0 0%
Unknown 7 41%
Readers by discipline Count As %
Nursing and Health Professions 3 18%
Medicine and Dentistry 3 18%
Social Sciences 1 6%
Engineering 1 6%
Unknown 9 53%